2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
Baptist Gallwitz(Universitätsklinikum Tübingen), Julio Rosenstock(Dallas Diabetes Research Center), T. Rauch(Boehringer Ingelheim (Germany)), Sudipta Bhattacharya(Boehringer Ingelheim (Germany)), Sanjay Patel(Boehringer Ingelheim (United Kingdom)), Maximilian von Eynatten(Boehringer Ingelheim (Germany)), Klaus A. Dugi(Boehringer Ingelheim (Germany)), Hans‐Juergen Woerle(Boehringer Ingelheim (Germany))
Cited by 339
Abstract
Related Papers
No related papers found
Powered by citation graph analysis